The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy: A Probabilistic Markov Model

Author： Pradelli Lorenzo   Iannazzo Sergio   Zaniolo Orietta  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.9, Iss.6, 2009-12, pp. : 383-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model

By Kreck Simon   Klaus Jochen  

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 311-328

Adis International

Access to resources Recommend Favorite

Valsartan: In Chronic Heart Failure

By Wellington K.   Goa K.L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 267-274

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Memantine in Alzheimer’s Disease: An Analysis Based on a Probabilistic Markov Model from a UK Perspective

By Roy W. Jones  

Drugs & Aging, Vol. 21, Iss. 9, 2004-01 ,pp. : 607-620

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Biventricular Pacemakers in Heart Failure Patients

By Heerey Adrienne  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 129-137

Adis International

Access to resources Recommend Favorite

Nesiritide Usage in Decompensated Heart Failure: Cost Effectiveness and Clinical Effectiveness

By  

Heart Drug, Vol. 5, Iss. 2, 2005-03 ,pp. : 81-88

Karger

Access to resources Recommend Favorite